Influence of diabetes on norepinephrine-induced inositol 1,4,5-trisphosphate levels in rat aorta

Worku Abebe, Kathleen M. MacLeod

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The effects of norepinephrine on total tissue levels of inositol 1,4,5-triphosphate were measured by protein binding assay in aortas from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. In both control and diabetic aortas, norepinephrine induced a rapid, transient and concentration-dependent elevation of inositol 1,4,5-trisphosphate content during contraction. Maximum production of inositol 1,4,5-trisphosphate in response to norepinephrine was greater in diabetic than in control aortas. However, the sensitivities of control and diabetic aortas to norepinephrine for inositol 1,4,5-trisphosphate production were not significantly different. Enhanced norepinephrine-induced production of inositol 1,4,5-trisphosphate in diabetic aortas may contribute to the increased maximum contractile responsiveness of these arteries to the agonist. However, since enhanced contractile responses of diabetic aortas to norepinephrine were also detected at times when inositol 1,4,5-trisphosphate levels were not significantly increased, other factors also appear to be involved in mediating enhanced contractions of diabetic arteries to norepinephrine.

Original languageEnglish (US)
JournalLife sciences
Volume49
Issue number13
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Inositol 1,4,5-Trisphosphate
Medical problems
Aorta
Rats
Norepinephrine
Arteries
Rat control
Experimental Diabetes Mellitus
Streptozocin
Protein Binding
Assays
Tissue

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Influence of diabetes on norepinephrine-induced inositol 1,4,5-trisphosphate levels in rat aorta. / Abebe, Worku; MacLeod, Kathleen M.

In: Life sciences, Vol. 49, No. 13, 01.01.1991.

Research output: Contribution to journalArticle

@article{4a0cc71f229342d582517455f852ba18,
title = "Influence of diabetes on norepinephrine-induced inositol 1,4,5-trisphosphate levels in rat aorta",
abstract = "The effects of norepinephrine on total tissue levels of inositol 1,4,5-triphosphate were measured by protein binding assay in aortas from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. In both control and diabetic aortas, norepinephrine induced a rapid, transient and concentration-dependent elevation of inositol 1,4,5-trisphosphate content during contraction. Maximum production of inositol 1,4,5-trisphosphate in response to norepinephrine was greater in diabetic than in control aortas. However, the sensitivities of control and diabetic aortas to norepinephrine for inositol 1,4,5-trisphosphate production were not significantly different. Enhanced norepinephrine-induced production of inositol 1,4,5-trisphosphate in diabetic aortas may contribute to the increased maximum contractile responsiveness of these arteries to the agonist. However, since enhanced contractile responses of diabetic aortas to norepinephrine were also detected at times when inositol 1,4,5-trisphosphate levels were not significantly increased, other factors also appear to be involved in mediating enhanced contractions of diabetic arteries to norepinephrine.",
author = "Worku Abebe and MacLeod, {Kathleen M.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0024-3205(91)90084-O",
language = "English (US)",
volume = "49",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "13",

}

TY - JOUR

T1 - Influence of diabetes on norepinephrine-induced inositol 1,4,5-trisphosphate levels in rat aorta

AU - Abebe, Worku

AU - MacLeod, Kathleen M.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The effects of norepinephrine on total tissue levels of inositol 1,4,5-triphosphate were measured by protein binding assay in aortas from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. In both control and diabetic aortas, norepinephrine induced a rapid, transient and concentration-dependent elevation of inositol 1,4,5-trisphosphate content during contraction. Maximum production of inositol 1,4,5-trisphosphate in response to norepinephrine was greater in diabetic than in control aortas. However, the sensitivities of control and diabetic aortas to norepinephrine for inositol 1,4,5-trisphosphate production were not significantly different. Enhanced norepinephrine-induced production of inositol 1,4,5-trisphosphate in diabetic aortas may contribute to the increased maximum contractile responsiveness of these arteries to the agonist. However, since enhanced contractile responses of diabetic aortas to norepinephrine were also detected at times when inositol 1,4,5-trisphosphate levels were not significantly increased, other factors also appear to be involved in mediating enhanced contractions of diabetic arteries to norepinephrine.

AB - The effects of norepinephrine on total tissue levels of inositol 1,4,5-triphosphate were measured by protein binding assay in aortas from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. In both control and diabetic aortas, norepinephrine induced a rapid, transient and concentration-dependent elevation of inositol 1,4,5-trisphosphate content during contraction. Maximum production of inositol 1,4,5-trisphosphate in response to norepinephrine was greater in diabetic than in control aortas. However, the sensitivities of control and diabetic aortas to norepinephrine for inositol 1,4,5-trisphosphate production were not significantly different. Enhanced norepinephrine-induced production of inositol 1,4,5-trisphosphate in diabetic aortas may contribute to the increased maximum contractile responsiveness of these arteries to the agonist. However, since enhanced contractile responses of diabetic aortas to norepinephrine were also detected at times when inositol 1,4,5-trisphosphate levels were not significantly increased, other factors also appear to be involved in mediating enhanced contractions of diabetic arteries to norepinephrine.

UR - http://www.scopus.com/inward/record.url?scp=0025896155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025896155&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(91)90084-O

DO - 10.1016/0024-3205(91)90084-O

M3 - Article

VL - 49

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 13

ER -